Why this decades-old antifungal remains a cornerstone of modern medical treatment

Health · Published 3 October 2026 Swipe more like this →

In short: Patented in 1981, fluconazole transformed how we manage fungal infections. As a first-generation triazole, it offers predictable oral absorption and systemic reach that earlier treatments lacked. While it remains a World Health Organization essential medicine, rising resistance and complex drug interactions are now shaping how clinicians prescribe this staple.

Fluconazole functions by inhibiting the fungal cytochrome P450 enzyme 14α-demethylase. This process blocks the conversion of lanosterol into ergosterol, a vital component of fungal cell membranes, effectively stopping fungal growth. Because mammalian demethylase is significantly less sensitive to the drug than its fungal counterpart, fluconazole can target infections while sparing human cells. It is primarily fungistatic, though it can act as a fungicidal agent against specific organisms like Cryptococcus when administered in higher doses.

The drug's clinical utility stems from its high bioavailability and reliable absorption, which are not hindered by stomach acid levels. Once ingested, it distributes widely throughout the body, reaching concentrations in urine, skin, and tears that are roughly ten times higher than those found in plasma. This makes it a preferred choice for systemic treatment of various Candida infections, as well as a prophylactic measure for high-risk patients, including those undergoing organ transplants or chemotherapy.

Despite its success, the emergence of resistance poses a significant challenge. Some fungal species, such as Candida albicans, have developed mutations in the ERG11 gene that prevent the drug from binding to its target. Others utilize efflux pumps to expel the medication from their cells. Current data indicates that approximately 7% of Candida strains in the United States exhibit resistance to the drug. To combat this, researchers are exploring combination therapies and the integration of phage therapy, which uses viruses to target and destroy resistant fungal strains.

Clinicians must also navigate a complex landscape of contraindications and drug interactions. Fluconazole inhibits the human cytochrome P450 system, particularly the CYP2C19 isozyme, which can lead to dangerous increases in the concentration of other medications. Furthermore, its potential to prolong the QT interval requires caution in patients already at risk for cardiac arrhythmias. While generally safe, its use during pregnancy is carefully monitored, as high doses in the first trimester have been linked to specific birth defects and an increased risk of spontaneous abortion.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Antifungal medicines stop fungal growth, but they must be used with careful medical guidance.
• A fungal drug with dangerous hormone-blocking powers
• Widespread use of antifungal chemicals is driving the rapid rise of drug resistance
• Is a warming planet forcing fungi to evolve into deadly human pathogens?
• Fungal disease hits over a billion people and killed millions in 2020
• General anaesthesia is a controlled state of unconsciousness, but how it works remains debated.
• Why your morning coffee or avocado toast might change how your medication works
• Hallucinogens alter reality by disrupting the brain's chemical communication networks
• Why the most advanced drug discovery process is still an expensive, inefficient gamble
• The hepatitis B vaccine is a highly effective shield against long-term liver damage.
• Why the most potent medicine in the world is useless if it misses its mark
• Why this decades-old antihistamine remains a go-to treatment for anxiety and sleep

More in Drugs and medication · More in Health · Latest · A–Z · All topics